Jiangsu Hengrui Medicine Co.,Ltd.’s Net Profit Rose 10.8% in First Half of 2023

Jiangsu Hengrui Medicine Co.,Ltd. (江苏恒瑞医药股份有限公司) (600276.SH) reported a net profit of 2.3 billion yuan in the first half of 2023, up 10.8% year-on-year.

Meanwhile, the company posted 11.2 billion yuan in revenue, up 9.2% year-on-year.

At the end of the reporting period, it had 42 billion yuan in total assets and 2.5 billion yuan in total liabilities, with a liability-to-asset ratio of 6%.